Evolution of the Average Target: Phio Pharmaceuticals Corp.

Evolution of the Target Price: Phio Pharmaceuticals Corp.

Changes in Analyst Recommendations: Phio Pharmaceuticals Corp.

1030e50.pjpCf_FHlw6XwtlQBiR4TwXBTC0suBW-UX5ydZsM9Kc.1l9xGrQ2xnav77JgU0EAFUOudW9O7n_7Fx8nOuFhuZLMSQVNkDfFYfiEiA~4ed7f5b5c3d5f4a65be5fe9e8b34c9a9

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +1,259.22%
+27.23%
+24.21%
+32.22%
+99.04%
+29.58%
-7.87%
-5.1%
+25.67%
+41.69%
Average +152.59%
Weighted average by Cap. +30.48%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.030USD
Average target price
14.00USD
Spread / Average Target
+1,259.22%
High Price Target
14.00USD
Spread / Highest target
+1,259.22%
Low Price Target
14.00USD
Spread / Lowest Target
+1,259.22%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.030USD
Average target price
14.00USD
Spread / Average Target
+1,259.22%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PHIO Stock
  4. Consensus Phio Pharmaceuticals Corp.